Article

Dr. Gorny named CEO of Carl Zeiss Vision

Aalen, Germany-Norbert Gorny, PhD, has been named chief executive officer of Carl Zeiss Vision International GmbH. He succeeds Jeremy Bishop, who had been CEO of the company since its inception in March 2005, when Carl Zeiss AG and SOLA International merged.

Aalen, Germany-Norbert Gorny, PhD, has been named chief executive officer of Carl Zeiss Vision International GmbH. He succeeds Jeremy Bishop, who had been CEO of the company since its inception in March 2005, when Carl Zeiss AG and SOLA International merged.

Dr. Gorny joined Carl Zeiss AG in 1998 as head of the Light Microscopy Division. For 5 years prior to joining the company, he was a business consultant with McKinsey & Co. Dr. Gorny subsequently was promoted to executive vice president of the company's Business Group and in 2001, he was appointed to the company's executive board. In this capacity, he oversaw corporate production departments and the European Sales subsidiaries as well as the Optronics and Photo divisions.

The company's North American headquarters is in San Diego.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.